Table9_5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Early Warning Biomarkers for COVID-19 Progression and Myocardial Injury.DOCX
Background: The symptoms of coronavirus disease 2019 (COVID-19) range from moderate to critical conditions, leading to death in some patients, and the early warning indicators of the COVID-19 progression and the occurrence of its serious complications such as myocardial injury are limited.
Methods: We carried out a multi-center, prospective cohort study in three hospitals in Wuhan. Genome-wide 5-hydroxymethylcytosine (5hmC) profiles in plasma cell-free DNA (cfDNA) was used to identify risk factors for COVID-19 pneumonia and develop a machine learning model using samples from 53 healthy volunteers, 66 patients with moderate COVID-19, 99 patients with severe COVID-19, and 38 patients with critical COVID-19.
Results: Our warning model demonstrated that an area under the curve (AUC) for 5hmC warning moderate patients developed into severe status was 0.81 (95% CI 0.77–0.85) and for severe patients developed into critical status was 0.92 (95% CI 0.89–0.96). We further built a warning model on patients with and without myocardial injury with the AUC of 0.89 (95% CI 0.84–0.95).
Conclusion: This is the first study showing the utility of 5hmC as an accurate early warning marker for disease progression and myocardial injury in patients with COVID-19. Our results show that phosphodiesterase 4D and ten-eleven translocation 2 may be important markers in the progression of COVID-19 disease.
History
References
- https://doi.org//10.1001/jamacardio.2020.1105
- https://doi.org//10.21203/rs.3.rs-94634/v1
- https://doi.org//10.1038/nature05874
- https://doi.org//10.1038/s41467-020-20001-w
- https://doi.org//10.1038/s41591-020-1051-9
- https://doi.org//10.1186/s13148-020-0810-2
- https://doi.org//10.1186/s13578-016-0121-7
- https://doi.org//10.1016/j.molcel.2016.06.028
- https://doi.org//10.3390/nu12061562
- https://doi.org//10.1017/S0950268820001557
- https://doi.org//10.1038/nmeth.1923
- https://doi.org//10.1093/bioinformatics/btp352
- https://doi.org//10.1038/cr.2017.121
- https://doi.org//10.1016/j.jinf.2020.06.053
- https://doi.org//10.1161/CIRCULATIONAHA.120.047549
- https://doi.org//10.4269/ajtmh.20-0564
- https://doi.org//10.1152/physiolgenomics.00089.2020
- https://doi.org//10.1002/0471250953.bi1112s47
- https://doi.org//10.1111/jcpt.13251
- https://doi.org//10.1016/j.cell.2020.05.032
- https://doi.org//10.1038/nbt.1732
- https://doi.org//10.1038/nn.2959
- https://doi.org//10.1242/dev.070771
- https://doi.org//10.3390/cells9061383
- https://doi.org//10.1016/j.tem.2016.04.006
- https://doi.org//10.1016/j.medmal.2020.03.007
- https://doi.org//10.1016/S0140-6736(20)30558-4
- https://doi.org//10.1038/s41591-020-0944-y
- https://doi.org//10.1001/jamainternmed.2020.0994
- https://doi.org//10.1093/nsr/nwaa086
- https://doi.org//10.1038/s42256-020-0180-7
- https://doi.org//10.1093/bioinformatics/btv145
- https://doi.org//10.2147/COPD.S106370
- https://doi.org//10.1016/j.devcel.2014.10.025
- https://doi.org//10.1186/s13613-020-00792-3
- https://doi.org//10.1111/jth.14859